August 22, 2025
Several of Rite Aid's executives have escaped a securities fraud suit accusing them of making misleading statements about the pharmacy retailer's opioid-related liabilities, with a Pennsylvania federal court finding they sufficiently cautioned investors about the company's ongoing legal battles.
January 17, 2024
Rite Aid shareholders urged a Pennsylvania federal court this week to not pause their class claims alleging company executives made misleading statements about the pharmacy retailer's opioid-related liabilities, asserting that the individuals named in the lawsuit are not covered by an automatic stay in the firm's ongoing Chapter 11 case.